CA2320031A1 - Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins - Google Patents

Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins Download PDF

Info

Publication number
CA2320031A1
CA2320031A1 CA002320031A CA2320031A CA2320031A1 CA 2320031 A1 CA2320031 A1 CA 2320031A1 CA 002320031 A CA002320031 A CA 002320031A CA 2320031 A CA2320031 A CA 2320031A CA 2320031 A1 CA2320031 A1 CA 2320031A1
Authority
CA
Canada
Prior art keywords
avec
avermitilis
cells
nucleotide sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002320031A
Other languages
English (en)
French (fr)
Inventor
Kim Jonelle Stutzman-Engwall
Yoshihiro Katoh
Hamish Alastair Irvine Mcarthur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002521289A priority Critical patent/CA2521289A1/en
Publication of CA2320031A1 publication Critical patent/CA2320031A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002320031A 1998-02-13 1999-01-25 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins Abandoned CA2320031A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002521289A CA2521289A1 (en) 1998-02-13 1999-01-25 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7463698P 1998-02-13 1998-02-13
US60/074,636 1998-02-13
PCT/IB1999/000130 WO1999041389A1 (en) 1998-02-13 1999-01-25 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002521289A Division CA2521289A1 (en) 1998-02-13 1999-01-25 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Publications (1)

Publication Number Publication Date
CA2320031A1 true CA2320031A1 (en) 1999-08-19

Family

ID=22120706

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002320031A Abandoned CA2320031A1 (en) 1998-02-13 1999-01-25 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
CA002521289A Abandoned CA2521289A1 (en) 1998-02-13 1999-01-25 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002521289A Abandoned CA2521289A1 (en) 1998-02-13 1999-01-25 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Country Status (32)

Country Link
EP (1) EP1053335A1 (enrdf_load_stackoverflow)
JP (2) JP2002503473A (enrdf_load_stackoverflow)
KR (3) KR20040053390A (enrdf_load_stackoverflow)
CN (2) CN1297485A (enrdf_load_stackoverflow)
AP (1) AP9901463A0 (enrdf_load_stackoverflow)
AR (1) AR018085A1 (enrdf_load_stackoverflow)
AU (1) AU752343C (enrdf_load_stackoverflow)
BG (1) BG64911B1 (enrdf_load_stackoverflow)
BR (1) BR9907893A (enrdf_load_stackoverflow)
CA (2) CA2320031A1 (enrdf_load_stackoverflow)
CO (1) CO5070698A1 (enrdf_load_stackoverflow)
DZ (1) DZ2720A1 (enrdf_load_stackoverflow)
EA (1) EA003905B1 (enrdf_load_stackoverflow)
GT (1) GT199900014A (enrdf_load_stackoverflow)
HN (1) HN1999000008A (enrdf_load_stackoverflow)
HR (1) HRP20000539A2 (enrdf_load_stackoverflow)
HU (1) HUP0100784A3 (enrdf_load_stackoverflow)
IL (2) IL137610A0 (enrdf_load_stackoverflow)
IS (1) IS5567A (enrdf_load_stackoverflow)
MA (1) MA24760A1 (enrdf_load_stackoverflow)
NO (1) NO20004044L (enrdf_load_stackoverflow)
NZ (2) NZ505676A (enrdf_load_stackoverflow)
OA (1) OA11449A (enrdf_load_stackoverflow)
PA (1) PA8467601A1 (enrdf_load_stackoverflow)
PE (1) PE20000352A1 (enrdf_load_stackoverflow)
PL (1) PL194270B1 (enrdf_load_stackoverflow)
SK (1) SK11722000A3 (enrdf_load_stackoverflow)
TN (1) TNSN99017A1 (enrdf_load_stackoverflow)
TW (1) TW585910B (enrdf_load_stackoverflow)
WO (1) WO1999041389A1 (enrdf_load_stackoverflow)
YU (1) YU50900A (enrdf_load_stackoverflow)
ZA (1) ZA991138B (enrdf_load_stackoverflow)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248579B1 (en) * 1998-02-13 2001-06-19 Pfizer Inc Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
CA2320031A1 (en) * 1998-02-13 1999-08-19 Pfizer Products Inc. Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
CN1186446C (zh) 1999-08-12 2005-01-26 辉瑞产品公司 介导除虫菌素b2:b1比例的除虫链霉茵基因
US7630836B2 (en) 2001-05-30 2009-12-08 The Kitasato Institute Polynucleotides
RU2293117C2 (ru) 2002-02-12 2007-02-10 Пфайзер Продактс Инк. Ген streptomyces avermitilis и его применение для изменения соотношения авермектинов b2:b1
CN107338210B (zh) * 2017-09-05 2021-08-17 天津科技大学 一种阿维链霉菌合成培养基及其发酵液的制备方法
CN111269296B (zh) * 2020-03-06 2021-11-05 山东大学 一种nLsA蛋白及其结构基因和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4429042A (en) * 1978-09-08 1984-01-31 Merck & Co., Inc. Strain of Streptomyces for producing antiparasitic compounds
IN167980B (enrdf_load_stackoverflow) * 1987-01-23 1991-01-19 Pfizer
DE3881147T2 (de) * 1987-10-23 1993-09-02 Pfizer Verfahren zur herstellung von aglykonen von avermectin und sie enthaltende kulturen.
JPH0747171B2 (ja) * 1988-09-20 1995-05-24 株式会社東芝 圧延機の設定方法および装置
US5252474A (en) * 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
ES2079436T3 (es) * 1989-03-31 1996-01-16 Merck & Co Inc Clonacion de genes de streptomyces avermitilis para biosintesis de avermectinas y procedimientos para su uso.
JP2888586B2 (ja) * 1990-03-05 1999-05-10 社団法人北里研究所 エバーメクチンの特定成分を選択生産するための微生物およびその選択的製造法
FI942725A7 (fi) * 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
CA2320031A1 (en) * 1998-02-13 1999-08-19 Pfizer Products Inc. Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Also Published As

Publication number Publication date
BG104759A (en) 2001-04-30
PE20000352A1 (es) 2000-05-16
JP4011036B2 (ja) 2007-11-21
CA2521289A1 (en) 1999-08-19
AU752343B2 (en) 2002-09-19
IL137610A0 (en) 2001-07-24
JP2002503473A (ja) 2002-02-05
KR20010052166A (ko) 2001-06-25
TNSN99017A1 (fr) 2005-11-10
IL183596A0 (enrdf_load_stackoverflow) 2007-09-20
AP9901463A0 (en) 1999-03-31
NO20004044D0 (no) 2000-08-11
MA24760A1 (fr) 1999-10-01
EA200000758A1 (ru) 2001-04-23
PA8467601A1 (es) 2000-09-29
KR100499214B1 (ko) 2005-07-07
BG64911B1 (bg) 2006-08-31
BR9907893A (pt) 2000-11-14
HN1999000008A (es) 1999-10-29
HRP20000539A2 (en) 2001-04-30
HUP0100784A2 (hu) 2001-06-28
AU752343C (en) 2005-11-03
GT199900014A (es) 2000-07-25
AR018085A1 (es) 2001-10-31
ZA991138B (en) 2000-08-14
CN1297485A (zh) 2001-05-30
SK11722000A3 (sk) 2001-04-09
PL342468A1 (en) 2001-06-04
AU1887899A (en) 1999-08-30
EP1053335A1 (en) 2000-11-22
OA11449A (en) 2003-12-03
KR20040099389A (ko) 2004-11-26
DZ2720A1 (fr) 2003-09-01
EA003905B1 (ru) 2003-10-30
PL194270B1 (pl) 2007-05-31
WO1999041389A1 (en) 1999-08-19
NZ505676A (en) 2003-02-28
IS5567A (is) 2000-07-20
TW585910B (en) 2004-05-01
CO5070698A1 (es) 2001-08-28
JP2004283174A (ja) 2004-10-14
YU50900A (sh) 2004-03-12
CN1521180A (zh) 2004-08-18
NZ518657A (en) 2003-10-31
HUP0100784A3 (en) 2004-10-28
NO20004044L (no) 2000-10-11
KR20040053390A (ko) 2004-06-23

Similar Documents

Publication Publication Date Title
AU752343B2 (en) Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
US6511841B2 (en) Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
US6632673B1 (en) Directing the ratio of B2:B1 avermectins in Streptomyces avermitilis host cells
CA2475214C (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
AU779569B2 (en) Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
MXPA00007915A (en) I(streptomyces avermitilis) gene directing the ratio of b2:b1 avermectins

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued